Portal de Periódicos da CAPES

The Current Outbreak of Kaposi's Sarcoma and Opportunistic Infections

1982; Wiley; Volume: 32; Issue: 6 Linguagem: Inglês

10.3322/canjclin.32.6.330

1542-4863

Harry W. Haverkos, James W. Curran,

Lymphoma Diagnosis and Treatment

CA: A Cancer Journal for CliniciansVolume 32, Issue 6 p. 330-339 ArticleFree Access The current outbreak of kaposi's sarcoma and opportunistic infections Harry W. Haverkos M.D, Harry W. Haverkos M.D An Epidemic Intelligence Service Officer and a member of the Task Force on the Acquired Immune Deficiency Syndrome of the Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, in Atlanta, GeorgiaSearch for more papers by this authorJames W. Curran M.D., M.P.H, James W. Curran M.D., M.P.H Coordinator of the Task Force on the Acquired Immune Deficiency Syndrome of the Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, in Atlanta, GeorgiaSearch for more papers by this author Harry W. Haverkos M.D, Harry W. Haverkos M.D An Epidemic Intelligence Service Officer and a member of the Task Force on the Acquired Immune Deficiency Syndrome of the Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, in Atlanta, GeorgiaSearch for more papers by this authorJames W. Curran M.D., M.P.H, James W. Curran M.D., M.P.H Coordinator of the Task Force on the Acquired Immune Deficiency Syndrome of the Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, in Atlanta, GeorgiaSearch for more papers by this author First published: November/December 1982 https://doi.org/10.3322/canjclin.32.6.330Citations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Centers for Disease Control: Pneumocystis pneumonia—Los Angeles. MMWR 30: 250– 252, 1981. 2 Centers for Disease Control: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. MMWR 30: 305– 308, 1981. 3 Kaposi M: Idiopathisches multiples Pigment-sarkom der Haut. Archive für Dermatologie und Syphillis 4: 265– 273, 1872. 4 Safai B, Good RA: Kaposi's sarcoma: a review and recent developments. CA 31: 2– 12, 1981. 5 Lutzner MA, Ziegler JS: Kaposi's sarcoma (multiple idiopathic hemorrhagic sarcoma), in TB Kirkpatrick (ed): Dermatology in Internal Medicine. New York, Oxford University Press, 1979, pp 742– 749. 6 Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973–1977. NCI Monogr 57, NIH Publication No 81–2330. Bethesda, Md, National Cancer Institute, 1981. 7 Safai B, Mike V, Giraldo G, et al: Association of Kaposi's sarcoma with second primary malignancies. Cancer 45: 1472– 1479, 1980. 8 Myers BD, Kessler E, Levi J, et al: Kaposi's sarcoma in kidney transplant recipients. Arch Intern Med 133: 307– 311, 1974. 9 Hardy MA, Goldfarb P, Levine S, et al: De novo Kaposi's sarcoma in renal transplantation: case report and brief review. Cancer 38: 144– 148, 1976. 10 Harwood AR, Osoba D, Hofstader SL, et al: Kaposi's sarcoma in recipients of renal transplants. Am J Med 67: 759– 765, 1979. 11 Penn I: Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 27: 8– 11, 1979. 12 Stribling J, Weitzner S, Smith GV: Kaposi's sarcoma in renal allograft recipients. Cancer 42: 442– 446, 1978. 13 Iversen OH, Wettland P, Jervell JA, et al: Kaposi's sarcoma in a renal allograft recipient under long-term immunosuppressive therapy. Scand J Urol Nephrol 14: 125– 128, 1980. 14 Gange RW, Jones EW: Kaposi's sarcoma and immunosuppressive therapy: an appraisal. Clin Exp Dermatol 3: 135– 146, 1978. 15 Klein MB, Pereira FA, Kantor I: Kaposi's sarcoma complicating systemic lupus erythematosus treated with immunosuppression. Arch Dermatol 110: 602– 604, 1974. 16 Hoshaw RA, Schwartz RA: Kaposi's sarcoma after immunosuppressive therapy with prednisone. Arch Dermatol 116: 1280– 1282, 1980. 17 Klepp O, Dahl O, Stenwig JT: Association of Kaposi's sarcoma and prior immunosuppressive therapy: a five-year material of Kaposi's sarcoma in Norway. Cancer 42: 2626– 2630, 1978. 18 Leung F, Fam AG, Osoba D: Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis. Am J Med 71: 320– 322, 1981. 19 Oettle AG: Geographical and racial differences in the frequency of Kaposi's sarcoma as evidence of environmental or genetic causes. Acta Unio Int Contra Cancrum 18: 330– 363, 1962. 20 Taylor JF, Templeton AC, Vogel CL, et al: Kaposi's sarcoma in Uganda: a clinicopathological study. Int J Cancer 8: 122– 135, 1971. 21 Taylor JF, Smith PG, Bull D, et al: Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Br J Cancer 26: 483– 497, 1972. 22 Hughes WT, Feldman S, Chaudhary S, et al: Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92: 285– 291, 1978. 23 Winston DJ, Lau WK, Gale RP, et al: Trimethoprim-sulfamethoxazole for the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 92: 762– 769, 1980. 24 Lau WK, Young LS: Trimethoprim-sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295: 716– 718, 1976. 25 Sattler FR, Remington JS: Intravenous trimethoprim-sulfamethoxazole therapy for Pneumocystis carinii pneumonia. Am J Med 70: 1215– 1221, 1981. 26 Walzer PD, Perl DP, Krogstad DJ, et al: Pneumocystis carinii in the United States: epidemiologic, diagnostic, and clinical features. Ann Intern Med 80: 83– 93, 1974. 27 Gajdusek DC: Pneumocystis carinii—etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics 19: 543– 565, 1957. 28 Hughes WT, Price RA, Sisko F, et al: Protein-calorie malnutrition: a host determinant for Pneumocystis carinii infection. Am J Dis Child 128: 44– 52, 1974. 29 Kinsey AC, Pomeroy WB, Martin CE: Sexual behavior in the human male. Philadelphia, WB Saunders Co, 1948. 30 Gottlieb GJ, Ragaz A, Vogel JV, et al: A preliminary communication on extensively disseminated Kaposi's sarcoma in young homosexual men. Am J Dermatopathol 3: 111– 114, 1981. 31 Hymes KB, Cheung T, Greene JB, et al: Kaposi's sarcoma in homosexual men—a report of eight cases. Lancet 2: 598– 600, 1981. 32 Masur H, Michelis MA, Greene JB, et al: An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305: 1431– 1438, 1981. 33 McDonough RJ, Madden JJ, Falek A, et al: Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 125: 2539– 2543, 1980. 34 Brown SM, Stimmel B, Taub RN, et al: Immunologic dysfunction in heroin addicts. Arch Intern Med 134: 1001– 1006, 1974. 35 Giraldo G, Beth E, Haguenau F: Herpestype virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. JNCI 49: 1509– 1513, 1972. 36 Giraldo G, Beth E, Huang ES: Kaposi's sarcoma and its relationship to cytomegalovirus (CMV). III. CMV DNA and CMV early anTIGens in Kaposi's sarcoma. Int J Cancer 26: 23– 29, 1980. 37 Boldogh I, Beth E, Huang ES, et al: Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA, and CMNA in tumor biopsies. Int J Cancer 28: 469– 474, 1981. 38 Giraldo G, Beth E, Kourilsky FM, et al: Antibody patterns to herpesviruses in Kaposi's sarcoma: serological association of Europeans with cytomegalovirus. Int J Cancer 15: 839– 848, 1975. 39 Giraldo G, Beth E, Henle W, et al: Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Int J Cancer 22: 126– 131, 1978. 40 Ryning FW, Mills J: Pneumocystis carinii, Toxoplasma gondii, cytomegalovirus, and the compromised host. West J Med 130: 18– 34, 1979. 41 Rinaldo Cr Jr, Carney WP, Richter BS, et al: Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis 141: 488– 495, 1980. 42 Drew WL, Mintz L, Miner RC, et al: Prevalence of cytomegalovirus infection in homosexual men. J Infect Dis 143: 188– 192, 1981. 43 Gottlieb MS, Schroff R, Schanker HM, et al: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305: 1425– 1431, 1981. 44 Centers for Disease Control Task Force on Kaposi's Sarcoma and Opportunistic Infections: Epidemiologic aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med 306: 248– 252, 1982. 45 Darrow WW, Barrett D, Jay K, et al: The gay report on sexually transmitted diseases. Am J Public Health 71: 1004– 1011, 1981. 46 Owen WF Jr: Sexually transmitted diseases and traumatic problems in homosexual men. Ann Intern Med 92: 805– 808, 1980. 47 Gallo RC, Reitz MS Jr: Molecular probes for tumor viruses in human cancer. Int Rev Exp Pathol 161: 1– 58, 1976. 48 Poiesz BJ, Ruscetti FW, Gazdar AF, et al: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci 77: 7415– 7419, 1980. 49 Kalyanaraman VS, Sarngadharan MG, Nakao Y, et al: Natural antibodies to the structural core protein (p24) of the human T-cell leukemia (lymphoma) retrovirus found in sera of leukemia patients in Japan. Proc Natl Acad Sci 79: 1653– 1657, 1982. Citing Literature Volume32, Issue6November/December 1982Pages 330-339 ReferencesRelatedInformation